Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI)
PHASE1CompletedINTERVENTIONAL
Enrollment
5
Participants
Timeline
Start Date
December 31, 2006
Study Completion Date
May 31, 2007
Conditions
Traumatic Brain Injury
Interventions
DRUG
Sublingual Tizanidine HCl
Trial Locations (1)
01090
Alyn Hospital Pediatric and Adolescent Rehabilitation Center, Jerusalem
All Listed Sponsors
lead
Teva GTC
INDUSTRY
NCT00287157 - Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI) | Biotech Hunter | Biotech Hunter